Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease
Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease have?
Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease has 982 citations in the OpenAlex counts ScholarIQ stores.
When was Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease published?
Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease has 2006 year in the ScholarIQ index.
What is the open-access status of Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease?
Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease has closed oa status in the ScholarIQ index.
What is the DOI of Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease?
The DOI for Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease is on the source record.
What is the PMID of Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease?
The PMID for Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease is on the source record.
What is the OpenAlex record for Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease?
The OpenAlex for Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease is on the source record.